
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A digital health company in the UK seeks a Genome Analyst for a 12-month fixed term role. You will analyze exome and genome data, draft reports for Clinical Scientists, and collaborate closely with a clinical team. Ideal candidates will have a BSc/MSc in Genetics, experience with NGS data, and excellent communication skills. Benefits include company pension, medical insurance, and remote work options. This role is pivotal in supporting the diagnosis of patients with genetic disorders.
12 MONTHS, FIXED TERM HINXTON (HUB-BASED, HYBRID)
Working with Clinical Scientists in the Clinical Team, you will provide analysis and interpretation of exome and genome data to support successful delivery of Congenica’s Interpretation Services. This includes variant filtering, analysis, interpretation and reporting for families referred with suspected rare genetic disease. This would be a suitable role for an individual looking to gain and expand their experience before applying to the NHS Clinical Scientist Training Programme (STP). Please note this is a data interpretation role and does not include a significant bioinformatics component.
Location: Hybrid/remote (UK based)
A Genome Analyst with expertise analysing exomes and genome data to diagnose patients with germline disorders. Specifically, should have:
Job Type: Fixed term contract Contract length: 12 months
Work Location: Hybrid remote in Hinxton, CB10 1DR
Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. As of September 2025, Congenica is part of the Seqone family: www.seqone.com. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide.
Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. We have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.